Search results
Results from the WOW.Com Content Network
Pravastatin, sold under the brand name Pravachol among others, is a statin medication, used for preventing cardiovascular disease in those at high risk and treating abnormal lipids. [5] It is suggested to be used together with diet changes, exercise, and weight loss. [ 5 ]
Certain statins, though, are less likely to be linked with myalgia. Those include pravastatin (Pravachol), fluvastatin (Lescol), rosuvastatin (Crestor), and pitavastatin (Livalo), says Dr. Blumenthal.
Myalgia or muscle pain is a painful sensation evolving from muscle tissue.It is a symptom of many diseases.The most common cause of acute myalgia is the overuse of a muscle or group of muscles; another likely cause is viral infection, especially when there has been no injury.
Mevastatin has since been derivatized to the compound pravastatin, which is a pharmaceutical used in the lowering of cholesterol and preventing cardiovascular disease. In vitro, it has antiproliferative properties. [4] A British group isolated the same compound from Penicillium brevicompactum, named it compactin, and published their results in ...
They will likely run blood tests to check for nutrient and hormone deficiencies, and screen for health conditions that cause fatigue, Ascher says. If it turns out that you do have a health issue ...
Lethargy is a state of tiredness, sleepiness, weariness, fatigue, sluggishness, or lack of energy. It can be accompanied by depression , decreased motivation, or apathy . Lethargy can be a normal response to inadequate sleep, overexertion, overworking, stress, lack of exercise, improper nutrition, drug abuse, boredom , or a symptom of an ...
The drugs that can cause hair loss include antihypertensive medications (such as ACE inhibitors or beta-blockers), cancer medications, statins, anticoagulants, antidepressants and medications that ...
Decreased all-cause mortality: There was a 22% reduction in all-cause mortality in the pravastatin group. Fewer revascularization procedures: In the pravastatin group, the need for coronary artery bypass grafting (CABG) or percutaneous coronary intervention (PCI) was reduced by 37%.